×
ADVERTISEMENT

DECEMBER 20, 2023

Advances in Pharmacotherapy for Narcolepsy and Idiopathic Hypersomnia

Laura Koppen, PharmD, BCPS
Clinical Assistant Professor
University of Illinois at Chicago College of Pharmacy

Narcolepsy and idiopathic hypersomnia (IH) are central disorders of hypersomnolence, characterized by excessive daytime sleepiness (EDS) and/or excessive need for sleep.1

Historically, narcolepsy has been estimated to affect 0.025% to 0.05% of the population worldwide (approximately 25 to 50 per 100,000 persons).2,3 A recent study of US claims data estimated an even higher prevalence of